United Therapeutics Corporation
|Company Name||United Therapeutics Corporation|
On July 27, 2017, the Company disclosed that it recorded a $210 million accrual relating to a potential settlement in connection with a DOJ investigation into the Company’s possible violations of the Federal Anti-Kickback Statute and the Federal False Claims Act.
On this news, the Company’s stock price fell approximately 5% during intraday trading on July 27, 2017.
Submit Your Information
If you suffered a loss on your United Therapeutics Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.
An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.